Home » Topics » BioWorld Science

BioWorld Science
RSS

Zika and testosterone don't mix

Sep. 19, 2018

CRISPR plus unusual cell line give insight into rare BRCA variants

Sep. 19, 2018

Tumor oxygen boost improves radiation response

Sep. 19, 2018

IMV reports initial data from phase II trial of DPX-Survivac in DLBCL

Sep. 18, 2018

Phase II trial of VK-2809 in patients with NAFLD and elevated LDL-C meets primary endpoint

Sep. 18, 2018

AmpliPhi Biosciences provides updates regarding the development of its bacteriophage therapeutics

Sep. 18, 2018

Sosei suspends HTL-0018318 clinical development following unexpected animal study finding

Sep. 18, 2018

European researchers present new data on compounds against Trypanosoma brucei

Sep. 18, 2018

Aurigene's oral CD47 antagonist AU7R-104 completing IND-enabling studies

Sep. 18, 2018

LEO Pharma and MorphoSys expand strategic alliance

Sep. 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...